Status:
UNKNOWN
Effect of General Anesthesia on Enterocyte Damage
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
Non-urgent Surgery
General Anesthesia
Eligibility:
All Genders
18+ years
Brief Summary
During non urgent surgery, general anesthesia might induce enterocyte damage. I-FABP is a performant biomarker of enterocyte damage. We aimed to study whether patient ongoing general anesthesia for no...
Detailed Description
Inclusion criteria * Indication of non-urgent surgery * General anesthesia protocol using propofol and remifentanyl * One half of the patients have a history of ischemic arteriopathy * One half of th...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Indication of non-urgent surgery
- General anesthesia protocol using propofol and remifentanyl
- One half of the patients have a history of ischemic arteriopathy
- One half of the patients have no history of ischemic arteriopathy
- Exclusion criteria
- Age \< 18 years old
- Pregnant
Exclusion
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2014
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02199275
Start Date
August 1 2013
End Date
August 1 2014
Last Update
July 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Besançon
Besançon, France, 25030